Can-Fite BioPharma CANF
NYSE CANF
$2.22 +0.04 (+2.07%)
As of: Sep 30, 2026 · 1:10 PM EDT

Can-Fite BioPharma Ltd. (CANF) EV to EBIT (2016 - 2017)

Updated

Can-Fite BioPharma's EV to EBIT was 463.62 in Q3 2017, up 7.1% from the prior quarter.

Analysis

Can-Fite BioPharma Ltd. (CANF) EV to EBIT (2016 - 2017) Analysis & Trends

On a trailing twelve-month basis, Can-Fite BioPharma's EV to EBIT was 460.35 through Sep 30, 2017; for FY2016, it was 567.35.

  • Quarterly EV to EBIT has moved between 432.71 (Q2 2017) and 773.66 (Q1 2017) over five years.
  • Per Business Quant data, CANF's EV to EBIT in the three quarters before Q3 2017 was 432.71 (Q2 2017), 773.66 (Q1 2017) and 568.36 (Q4 2016).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 463.62
Jun 30, 2017 432.71
Mar 31, 2017 773.66
Dec 31, 2016 568.36
API Access

Can-Fite BioPharma Ltd. EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CANF&period=max&api_key=YOUR_API_KEY